Ye SL - Search Results

1

Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.

Marrero JA, Kudo M, Venook AP, Ye SL, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JH, de Guevara LL, Papandreou C, Takayama T, Sanyal AJ, Yoon SK, Nakajima K, Lehr R, Heldner S, Lencioni R. Marrero JA, et al. Among authors: ye sl. J Hepatol. 2016 Dec;65(6):1140-1147. doi: 10.1016/j.jhep.2016.07.020. Epub 2016 Jul 25. J Hepatol. 2016. PMID: 27469901

2

[Present status and evaluation of interventional therapy for primary hepatocellular carcinoma].

Ye S. Ye S. Zhonghua Gan Zang Bing Za Zhi. 2002 Jun;10(3):165-6. Zhonghua Gan Zang Bing Za Zhi. 2002. PMID: 12113666 Chinese. No abstract available.

3

[Prospect of hepatocellular carcinoma in 2008].

Ye SL. Ye SL. Zhonghua Gan Zang Bing Za Zhi. 2009 Jan;17(1):7-9. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19391280 Chinese. No abstract available.

4

Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion.

Chen PJ, Furuse J, Han KH, Hsu C, Lim HY, Moon H, Qin S, Ye SL, Yeoh EM, Yeo W. Chen PJ, et al. Among authors: ye sl. Liver Int. 2010 Nov;30(10):1427-38. doi: 10.1111/j.1478-3231.2010.02292.x. Liver Int. 2010. PMID: 20557456 Review.

5

Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.

Chen RX, Xia YH, Cui JF, Xue TC, Ye SL. Chen RX, et al. Among authors: ye sl. J Gastroenterol Hepatol. 2010 Aug;25(8):1435-42. doi: 10.1111/j.1440-1746.2010.06277.x. J Gastroenterol Hepatol. 2010. PMID: 20659235

6

[Effect of postoperative adjuvant transarterial chemoembolization on late recurrence of hepatocellular carcinoma after radical resection].

Chen XH, Zhang BH, Qiu SJ, Fan J, Ren ZG, Xia JL, Wang YH, Gan YH, Yin X, Ye SL. Chen XH, et al. Among authors: ye sl. Zhonghua Gan Zang Bing Za Zhi. 2010 Aug;18(8):599-603. doi: 10.3760/cma.j.issn.1007-3418.2010.08.012. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 20825715 Clinical Trial. Chinese.

7

Current approaches to the treatment of early hepatocellular carcinoma.

Ye SL, Takayama T, Geschwind J, Marrero JA, Bronowicki JP. Ye SL, et al. Oncologist. 2010;15 Suppl 4:34-41. doi: 10.1634/theoncologist.2010-S4-34. Oncologist. 2010. PMID: 21115579 Free article. Review.

8

[Therapeutic efficacy and prognostic factors of sorafenib treatment in patients with unresectable primary hepatocellular carcinoma].

Zhang L, Ren ZG, Gan YH, Wang YH, Zhang BH, Chen Y, Xie XY, Ge NL, Ye SL. Zhang L, et al. Among authors: ye sl. Zhonghua Zhong Liu Za Zhi. 2010 Aug;32(8):630-3. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21122420 Chinese.

9

[Application of interferon in the treatment of liver cancer].

Zhang JB, Ye SL. Zhang JB, et al. Among authors: ye sl. Zhonghua Gan Zang Bing Za Zhi. 2011 Jan;19(1):11-2. doi: 10.3760/cma.j.issn.1007-3418.2011.01.006. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 21272452 Chinese. No abstract available.

10

Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization.

Zhang JB, Chen Y, Zhang B, Xie X, Zhang L, Ge N, Ren Z, Ye SL. Zhang JB, et al. Among authors: ye sl. Eur J Gastroenterol Hepatol. 2011 Sep;23(9):787-93. doi: 10.1097/MEG.0b013e32834902dd. Eur J Gastroenterol Hepatol. 2011. PMID: 21730869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page